1 May 2025 false Taxfiler 2024.6 11963343 business:PrivateLimitedCompanyLtd 2025-05-01 2026-04-30 11963343 2025-04-30 11963343 2025-05-01 2026-04-30 11963343 business:AuditExemptWithAccountantsReport 2025-05-01 2026-04-30 11963343 business:FilletedAccounts 2025-05-01 2026-04-30 11963343 2026-04-30 11963343 business:Director1 2025-05-01 2026-04-30 11963343 business:Director2 2025-05-01 2026-04-30 11963343 business:RegisteredOffice 2025-05-01 2026-04-30 11963343 2025-04-30 11963343 core:WithinOneYear 2026-04-30 11963343 core:WithinOneYear 2025-04-30 11963343 core:AfterOneYear 2026-04-30 11963343 core:AfterOneYear 2025-04-30 11963343 core:ShareCapital core:PreviouslyStatedAmount 2026-04-30 11963343 core:ShareCapital core:PreviouslyStatedAmount 2025-04-30 11963343 core:RetainedEarningsAccumulatedLosses core:PreviouslyStatedAmount 2026-04-30 11963343 core:RetainedEarningsAccumulatedLosses core:PreviouslyStatedAmount 2025-04-30 11963343 core:PreviouslyStatedAmount 2026-04-30 11963343 core:PreviouslyStatedAmount 2025-04-30 11963343 business:SmallEntities 2025-05-01 2026-04-30 11963343 countries:EnglandWales 2025-05-01 2026-04-30 11963343 core:ComputerEquipment 2025-05-01 2026-04-30 11963343 core:LandBuildings 2025-04-30 11963343 core:ComputerEquipment 2025-04-30 11963343 core:LandBuildings 2026-04-30 11963343 core:ComputerEquipment 2026-04-30 11963343 core:LandBuildings 2025-05-01 2026-04-30 11963343 business:OrdinaryShareClass1 2025-05-01 2026-04-30 11963343 business:OrdinaryShareClass1 2024-05-01 2025-04-30 11963343 business:Director2 1 2025-05-01 2026-04-30 11963343 business:Director2 1 2025-04-30 11963343 business:Director2 1 2026-04-30 11963343 2024-05-01 2025-04-30 iso4217:GBP xbrli:shares xbrli:pure
Company Registration No. 11963343 (England and Wales)
SWM PHARMA SOLUTIONS LIMITED Unaudited accounts for the year ended 30 April 2026
SWM PHARMA SOLUTIONS LIMITED Unaudited accounts Contents
Page
Company information
3
Statement of financial position
4
Notes to the accounts
5
- 2 -
SWM PHARMA SOLUTIONS LIMITED Company Information for the year ended 30 April 2026
Directors
Waseem Nawaz Ashtons Healthcare Solutions Ltd
Company Number
11963343 (England and Wales)
Registered Office
833 Moss Bank Way Bolton BL1 5SN
Accountants
Olaando Consulting Ltd 7 Bell Yard London WC2A 2JR
- 3 -
SWM PHARMA SOLUTIONS LIMITED Statement of financial position as at 30 April 2026
2026
2025
Notes
£
£
Fixed assets
Tangible assets
4
309,780
311,825
Investments
5
37,150
37,150
346,930
348,975
Current assets
Inventories
10,000
-
Debtors
6
207,736
159,445
Cash at bank and in hand
118,363
140,225
336,099
299,670
Creditors: amounts falling due within one year
7
(23,931)
(46,120)
Net current assets
312,168
253,550
Total assets less current liabilities
659,098
602,525
Creditors: amounts falling due after more than one year
8
(207,970)
(207,970)
Net assets
451,128
394,555
Capital and reserves
Called up share capital
9
100
100
Profit and loss account
451,028
394,455
Shareholders' funds
451,128
394,555
For the year ending 30 April 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board of Directors and authorised for issue on 31 July 2026 and were signed on its behalf by
Waseem Nawaz Director Company Registration No. 11963343
- 4 -
SWM PHARMA SOLUTIONS LIMITED Notes to the Accounts for the year ended 30 April 2026
1
Statutory information
SWM PHARMA SOLUTIONS LIMITED is a private company, limited by shares, registered in England and Wales, registration number 11963343. The registered office is 833 Moss Bank Way , Bolton , BL1 5SN.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. Turnover from the sale of goods is recognised when goods have been delivered to customers such that risks and rewards of ownership have transferred to them. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Inventories
Inventories have been valued at the lower of cost and estimated selling price less costs to complete and sell. In respect of work in progress and finished goods, cost includes a relevant proportion of overheads according to the stage of manufacturing/completion.
Pension costs
The company operates a defined contribution scheme for the benefit of its employees. Contributions payable are recognised in the profit and loss account when due.
Government grants
Government grants in relation to tangible fixed assets are credited to profit and loss account over the useful lives of the related assets, whereas those in relation to expenditure are credited when the expenditure is charged to profit and loss.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Computer equipment
33% Straight line
- 5 -
SWM PHARMA SOLUTIONS LIMITED Notes to the Accounts for the year ended 30 April 2026
4
Tangible fixed assets
Land & buildings
Computer equipment
Total
£
£
£
Cost or valuation
At cost
At cost
At 1 May 2025
309,780
9,607
319,387
At 30 April 2026
309,780
9,607
319,387
Depreciation
At 1 May 2025
-
7,562
7,562
Charge for the year
-
2,045
2,045
At 30 April 2026
-
9,607
9,607
Net book value
At 30 April 2026
309,780
-
309,780
At 30 April 2025
309,780
2,045
311,825
5
Investments
Other investments
£
Valuation at 1 May 2025
37,150
Valuation at 30 April 2026
37,150
6
Debtors
2026
2025
£
£
Amounts falling due within one year
VAT
28,324
28,445
Other debtors
12,500
-
40,824
28,445
Amounts falling due after more than one year
Other debtors
166,912
131,000
7
Creditors: amounts falling due within one year
2026
2025
£
£
Taxes and social security
19,434
39,313
Other creditors
3,427
5,727
Accruals
1,070
1,080
23,931
46,120
8
Creditors: amounts falling due after more than one year
2026
2025
£
£
Other creditors
52,000
52,000
Loans from directors
155,970
155,970
207,970
207,970
- 6 -
SWM PHARMA SOLUTIONS LIMITED Notes to the Accounts for the year ended 30 April 2026
9
Share capital
2026
2025
£
£
Allotted, called up and fully paid:
100 Ordinary shares of £1 each
100
100
10
Loans to directors
Brought Forward
Advance/ credit
Repaid
Carried Forward
£
£
£
£
Ashtons Healthcare Solutions Ltd
Loans from Director
155,970
-
-
155,970
155,970
-
-
155,970
11
Average number of employees
During the year the average number of employees was 4 (2025: 14).
- 7 -